--- name: Amador Bioscience slug: amadorbioscience site: cro website_domain: amadorbioscience.com summary: Amador Bioscience provides bioanalysis and biomarker services, including LCMS, immunoassays, flow cytometry, and immunogenicity testing, alongside clinical pharmacology modeling and regulatory affairs support. Its labs are GLP compliant, and its teams work across the US, China, and Europe. Headquartered in United States. tagline: Global Expertise. Local Solutions. founded_year: employee_count_band: employee_count_label: parent_name: parent_slug: hq_country: US tier2_domain_verified: false updated_at: 2026-11-04T07:02:17.646Z services_count: 12 modalities_count: 9 indications_count: 0 locations_count: 7 review_signal_gate: closed generated_by: BioBM Editorial AI --- # Amador Bioscience Global Expertise. Local Solutions. Listed on cro.directory. ## Summary Amador Bioscience provides bioanalysis and biomarker services, including LCMS, immunoassays, flow cytometry, and immunogenicity testing, alongside clinical pharmacology modeling and regulatory affairs support. Its labs are GLP compliant, and its teams work across the US, China, and Europe. Headquartered in United States. ## At a glance - HQ country: US ## Services - Bioanalysis - Ligand-Binding Bioanalysis (Large Molecule) - LC-MS Bioanalysis (Small Molecule) - Immunogenicity Assays (ADA / NAb) - Flow Cytometry Services - Biomarker Assays - Biostatistics & Statistical Programming - Translational Research - Regulatory Affairs - Clinical Trial Services - Clinical Operations - Phase IV / Post-Marketing ## Modalities - Antibody-Drug Conjugate (ADC) - Oligonucleotide - Peptide - Small Molecule - Cell Therapy - Gene Therapy - mRNA - Vaccine - Biologics (Other) ## Locations - California, California, United States - Maryland, Maryland, United States - Michigan, Michigan, United States - Belgium, Belgium - Hangzhou, Hangzhou, China - Shanghai, Shanghai, China - Beijing, Beijing, China ## Long description ## Overview Amador Bioscience describes itself as a global CRO offering translational science, clinical pharmacology, bioanalysis and biomarkers, and regulatory submission services in the US, China, and Europe. The company positions its work as a bridge from early research through approval, and states it is a full-service CRO for drug development from preclinical research to Clinical Phase IV studies. ## Bioanalysis and biomarkers - Immunoassays for protein and oligonucleotide therapies, biomarkers, and anti-drug antibodies (multiplex and ultrasensitive ELISA, MSD, Gyrolab, Luminex, SPX) - LCMS for antibody-drug conjugates, oligonucleotides, peptides, small molecules, and biomarkers (HR and triple quad MS) - Cell-based assays, including neutralizing anti-drug antibody and activity-based biomarkers - Flow cytometry for cell therapy and biomarker work, such as immunophenotyping and receptor occupancy - ELISpot assays for vaccine efficacy and cell-mediated immune response - Molecular biology for cell and gene therapy, RNA vaccines, and gene editing biomarkers (qPCR, ddPCR, RNA-Seq, NanoString, NGS) - Immunogenicity assessment, including risk assessment, assay development and validation, and regulatory documentation such as integrated immunogenicity summaries The company states it performs in-house GLP and GcLP sample analysis and operates three GLP compliant laboratories. ## Clinical pharmacology - Noncompartmental PK/TK analysis and reporting - Statistical programming, including SEND and SDTM datasets, and SAS-based tables, listings, and figures - Translational modeling and simulation for clinical PKPD projection and first-in-human dose recommendations - Population PKPD modeling, exposure-response analysis, and quantitative systems pharmacology - Model-informed drug development to support dose selection, trial design, and NDA, BLA, and MAA filings ## Regulatory affairs and clinical research Amador describes global regulatory and operational expertise for go-to-market goals. Its clinical research offering includes project management, clinical research, and biometrics, and it highlights a network of therapeutic-specific key opinion leaders and pre-qualified investigator trial sites in the United States, Europe, and China. ## Leadership The company states its leadership team has more than 100 years of combined industry experience. ## Related companies - [Swiss BioQuant AG](/companies/swissbioquant) (Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule)) — [Compare](/compare/amadorbioscience/swissbioquant) - [Celerion](/companies/celerion) (Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule)) — [Compare](/compare/amadorbioscience/celerion) - [Certara](/companies/certara) (Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule)) — [Compare](/compare/amadorbioscience/certara) - [ICON plc](/companies/iconplc) (Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule)) — [Compare](/compare/amadorbioscience/iconplc) - [NorthEast BioLab](/companies/nebiolab) (Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule)) — [Compare](/compare/amadorbioscience/nebiolab) - [SoCal Biosciences, Inc.](/companies/socalbiosci) (Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule)) — [Compare](/compare/amadorbioscience/socalbiosci) - [WuXi AppTec](/companies/wuxiapptec) (Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule)) — [Compare](/compare/amadorbioscience/wuxiapptec) - [Aragen Life Sciences](/companies/aragen) (Bioanalysis, Ligand-Binding Bioanalysis (Large Molecule)) — [Compare](/compare/amadorbioscience/aragen) _Profile last updated: 2026-11-04T07:02:17.646Z. Profile facts may include AI-assisted enrichment._ Auto-generated by BioBM Editorial AI for machine-readable profile access.